Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Añadir filtros








Intervalo de año
1.
Biol. Res ; 36(2): 233-240, July 2003. ilus, tab, graf
Artículo en Inglés | LILACS | ID: lil-351365

RESUMEN

Angiogenesis, the development of new blood vessels from the existing vascular network, may result as a consequence of the increase or decrease of proangiogenic or antiangiogenic factors, respectively. The tumor itself could up-regulate the production of angiogenic factors. Recently, we established that the steroidal drug betamethasone in low concentration inhibit the neovascularization promoted by TA3 Ts on CAM of chick embryos. We describe here the effects of the non-steroidal drug ketoprofen, alone or in association with betamethasone, on the angiogenesis promoted by TA3 Ts on CAM. The main finding reported here is that the formation of new blood vessels is strongly inhibited by low concentrations of ketoprofen. The association of both drugs produced a synergistic effect, significantly decreasing tumoral supernatant angiogenesis. It is known that steroidal anti-inflammatory drugs inhibit the enzymes required for the production of prostaglandins through a nuclear GR mediated mechanism. This may operate as a general mechanism in endothelial cells as well. Considering that the induction of COX 1 and COX2 are inhibited by ketoprofen, and that these enzymes are located in the stromal compartment of the CAM, we propose that its antiangiogenic effect may occur via inhibition of the two COX isoforms. In fact, we found that ketoprofen induced apoptosis in both the stromal fibroblast and endothelial cells. The potentiated effect of the combination of betamethasone and ketoprofen may have some therapeutic projections in the control of pathological angiogenesis


Asunto(s)
Animales , Antiinflamatorios , Betametasona , Cetoprofeno , Neovascularización Patológica , Antiinflamatorios no Esteroideos , Embrión de Pollo , Combinación de Medicamentos , Sinergismo Farmacológico , Proteínas de Neoplasias , Neoplasias Experimentales , Células Tumorales Cultivadas
2.
Biol. Res ; 35(3/4): 339-345, 2002. ilus, tab, graf
Artículo en Inglés | LILACS | ID: lil-339727

RESUMEN

In this study, we showed the effect of the betamethasone, sulindac and quinacrine alone or combined, on the inflammatory angiogenesis promoted by polyurethane sponge on mice. The main finding reported here is that the formation of new blood vessels was strongly inhibited by low concentration of betamethasone, sulindac or quinacrine, whether alone or in combination. It is known that steroidal anti-inflammatory drugs inhibit the enzymes required for the production of prostaglandins through a nuclear glucocorticoid receptor (GR) mediated mechanism. This mechanism may occur in endothelial cells as well. Considering that activity of cyclo-oxigenases 1 and 2 is inhibited by sulindac, and that these enzymes are located in the stromal tissue, we propose that the anti-angiogenic effect of these agents may occur via inhibition of both COX isoforms. On the other hand, quinacrine inhibited PLA2 activity, and we propose here that the anti-angiogenic effect occurs via inhibition of the enzyme PLA2. The potentiated effect of the association of betamethasone, sulindac and quinacrine may have some therapeutic benefit in the control of pathological angiogenesis. Further studies are required to validate these propositions


Asunto(s)
Animales , Femenino , Ratones , Antiinflamatorios no Esteroideos , Betametasona , Neovascularización Patológica , Quinacrina , Sulindac , Antiinflamatorios no Esteroideos , Apoptosis , Betametasona , Quimioterapia Combinada , Isoenzimas , Neovascularización Patológica , Poliuretanos , Prostaglandina-Endoperóxido Sintasas , Quinacrina , Sulindac , Tapones Quirúrgicos de Gaza
3.
Biol. Res ; 34(3/4): 227-236, 2001. ilus, tab, graf
Artículo en Inglés | LILACS | ID: lil-303886

RESUMEN

Tumor growth is the result of combined cell proliferation overwhelming cell death and neoangiogenesis. This report shows CAM angiogenesis promoted by TA3 tumor supernatant with or without low dosis of betamethasone (Minimal antiangiogenic concentration: beta-MAAC). Methylcellulose discs instilled with 10 microliters of beta-MAAC (0.08 microgram/ml), 10 microliters of tumor supernatant (TA3ts), 5 microliters beta-MAAC + 5 microliters TA3ts, and 10 microliters of PBS as control were implanted in host chick eggs. On day 12, the grafts were removed, photographed and fixed. Sections were stained in parallel, one and three with hematoxylin-eosin, and section two by the Tunel method. The number of vessels was evaluated in a microscopic field of the CAM (2250 micron 2). The results show that beta-MAAC produced a significant inhibition of neovascularization in comparison to that observed in controls (P < 0.0025; Student t-Test). Discs instilled with TA3ts produced an intense stimulation of angiogenesis in contrast, when discs were instilled with 5 microliters of beta-MAAC + 5 microliters of TA3ts the angiogenesis was significantly inhibited (P < 0.001). The results show that effective antiangiogenic doses of betamethasone are in the range of 10(-7) M, (probably a genomic mediated action) and that this effect of low concentration may have clinical applications.


Asunto(s)
Animales , Alantoides , Inhibidores de la Angiogénesis , Betametasona , Neovascularización Patológica , Alantoides , Inhibidores de la Angiogénesis , Betametasona , Embrión de Pollo , Corion , Endotelio Vascular , Sustancias de Crecimiento , Proteínas de Neoplasias , Neovascularización Patológica , Células Tumorales Cultivadas
4.
Rev. chil. anat ; 13(2): 177-82, 1995. ilus, tab
Artículo en Español | LILACS | ID: lil-175000

RESUMEN

Se acepta que los receptores de adhesión: MAC, cadherinas, integrinas y selectinas intervendrían en el destino de células inmunes. Además, controlarían la diseminación de tumores sólidos. Mediante técnicas ad hoc es posible aisla células cancerosas y traspasarlas a receptores. Una herramienta impostante en oncología experimental es la identificación de residuos glicosídicos mediante lectinas. En este trabajo estudiamos el pérfil glicosídico de céluas de un tumos ascítico experimental, mediante lectinas conjugadas con peroxidasa de rábano (lectina-HRP). Utilizamos ratones AJ portadores de las líneas tumorales TA3MTXR (resistente a metotrexato) y TA3 de menor malignidad. Las células fueron inoculadas por vía intramuscular, en ratones sanos. Se obtuvieron biopsias de nódulos primarios a los 7 y 21 días y nódulos metastásicos en corazón y pulmón a los 21 días. Los cortes fueron fijados e incubados en Con A, DBA, PNA, WGA y RCA. Como controles utilizamos azúcares inhibitorios específicos. La mayor intensidad correspondió a PNA en tumores primarios y metastásicos. Con A, WGA y DBA reaccionaron con intensidad menor. Se registraron diferencias entre metástasis cardíacas y pulmonares, en relación a Con A. No hubo reacción frente a RCA. Estos resultados muestran algunas diferencias entre residuos glicosídicos presentes a metastásis cardíacas y pulmonares, específicamente con respecto a manosa y glucosa. Aparentemente, no existirían mayores diferencias entre tumores primarios y metastásicos, con respecto a galactosa, N-acetil glucosamina y ácido siálico


Asunto(s)
Animales , Ratones , Células Neoplásicas Circulantes/química , Histocitoquímica/métodos , Carcinoma de Ehrlich , Células Neoplásicas Circulantes/ultraestructura , Citoplasma/ultraestructura , Lectinas , Líquido Ascítico/química , Microscopía Electrónica , Peroxidasa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA